Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sydney Stern

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2022
Clinical Relevance of the Constitutive Androstane ReceptorSydney Stern, Ritika Kurian, Hongbing Wang
Cells|June 10, 2023
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILISydney Stern, Hongbing Wang, Nakissa Sadrieh
Nucleic Acid Therapeutics|September 23, 2024
An Evaluation of First-in-Human Studies for RNA OligonucleotidesSydney Stern, Ronald L Wange, Hobart Rogers
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2018
The Roles of Xenobiotic Receptors: Beyond Chemical DispositionBryan Mackowiak, Jessica Hodge, Sydney Stern, et al.
Future Oncology (London, England)|October 8, 2024
Vimseltinib versus a placebo in patients with tenosynovial giant cell tumor: a plain language summary of the MOTION phase 3 trialNicholas M Bernthal, Sydney Stern, Jean-Yves Blay
Orphanet Journal of Rare Diseases|July 26, 2024
Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)Sydney Stern, Karryn Crisamore, Robert Schuck, et al.
Clinical and Translational Science|June 19, 2026
From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial DiseasesSydney Stern, Karryn Crisamore, John Patton, et al.
Frontiers in Pharmacology|March 25, 2022
17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB ActivationTao Hu, Chengjifu Tang, Sydney Stern, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 3, 2024
Leveraging in Vitro Models for Clinically Relevant Rare <i>CYP2D6</i> Variants in PharmacogenomicsSydney Stern, Paula L Hyland, Michael Pacanowski, et al.
Clinical and Translational Science|February 28, 2025
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 GangliosidosisSydney Stern, Karryn Crisamore, Ruo-Jing Li, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 3, 2022
Clinical Relevance of the Constitutive Androstane ReceptorSydney Stern, Ritika Kurian, Hongbing Wang
Cells|June 10, 2023
Microphysiological Models for Mechanistic-Based Prediction of Idiosyncratic DILISydney Stern, Hongbing Wang, Nakissa Sadrieh
Nucleic Acid Therapeutics|September 23, 2024
An Evaluation of First-in-Human Studies for RNA OligonucleotidesSydney Stern, Ronald L Wange, Hobart Rogers
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 16, 2018
The Roles of Xenobiotic Receptors: Beyond Chemical DispositionBryan Mackowiak, Jessica Hodge, Sydney Stern, et al.
Future Oncology (London, England)|October 8, 2024
Vimseltinib versus a placebo in patients with tenosynovial giant cell tumor: a plain language summary of the MOTION phase 3 trialNicholas M Bernthal, Sydney Stern, Jean-Yves Blay
Orphanet Journal of Rare Diseases|July 26, 2024
Evaluation of the landscape of pharmacodynamic biomarkers in Niemann-Pick Disease Type C (NPC)Sydney Stern, Karryn Crisamore, Robert Schuck, et al.
Clinical and Translational Science|June 19, 2026
From Pharmacodynamic Biomarker to Evaluating Treatment Response: Biomarkers in Primary Mitochondrial DiseasesSydney Stern, Karryn Crisamore, John Patton, et al.
Frontiers in Pharmacology|March 25, 2022
17α-Hydroxyprogesterone Caproate Inhibits Cytokine Production via Suppression of NF-κB ActivationTao Hu, Chengjifu Tang, Sydney Stern, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 3, 2024
Leveraging in Vitro Models for Clinically Relevant Rare <i>CYP2D6</i> Variants in PharmacogenomicsSydney Stern, Paula L Hyland, Michael Pacanowski, et al.
Clinical and Translational Science|February 28, 2025
Evaluation of the Landscape of Pharmacodynamic Biomarkers in GM1 and GM2 GangliosidosisSydney Stern, Karryn Crisamore, Ruo-Jing Li, et al.
Pageof 3